In early 2014, when George Cary stepped in to defend Sanofi-Aventis SA against claims that it had illegally cornered the market to provide hospitals with blood thinner, the company had already spent five years trying unsuccessfully to beat the multibillion-dollar litigation.
Less than four months later, after Cary argued for summary judgment, a federal judge in New Jersey agreed to toss the case. The Cleary Gottlieb Steen & Hamilton partner finished the job this week, convincing a federal appeals court that Japanese drugmaker Eisai Co. Ltd. didn’t back up its antitrust allegations against Sanofi.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
